General Information of Drug (ID: DMAI19Z)

Drug Name
PMID25468267-Compound-56 Drug Info
Cross-matching ID
PubChem CID
90093146
TTD Drug ID
DMAI19Z

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID25468267-Compound-46 DMSKCEH N. A. N. A. Patented [1]
Hydroxamate analog 1 DMGATHZ N. A. N. A. Patented [1]
Pyrido[1,2-a]indole-1.-carboxylic acid analog 4 DM09FOQ N. A. N. A. Patented [1]
Pyrido[1,2-a]indole-1.-carboxylic acid analog 1 DMF0XI3 N. A. N. A. Patented [1]
Pyrido[1,2-a]indole-1.-carboxylic acid analog 5 DMO3QDW N. A. N. A. Patented [1]
PMID25468267-Compound-47 DMG2JEK N. A. N. A. Patented [1]
Pyrido[1,2-a]indole-1.-carboxylic acid analog 7 DMXY3F0 N. A. N. A. Patented [1]
Pyrido[1,2-a]indole-1.-carboxylic acid analog 3 DMCLKBY N. A. N. A. Patented [1]
Flavonoid derivative 6 DM0E38G N. A. N. A. Patented [1]
PMID25468267-Compound-55 DMIXQRY N. A. N. A. Patented [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Lysine-specific demethylase 4C (KDM4C) TTV8CRH KDM4C_HUMAN Inhibitor [1]

References

1 KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.Expert Opin Ther Pat. 2015 Feb;25(2):135-44.